Geron Corp GERN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
1.27UNCH (UNCH)
Volume
46,614
Close
1.27quote price arrow down-0.06 (-4.51%)
Volume
1,695,288
52 week range
0.99 - 2.23
Loading...
  • Open1.34
  • Day High1.36
  • Day Low1.26
  • Prev Close1.33
  • 52 Week High2.23
  • 52 Week High Date06/18/21
  • 52 Week Low0.99
  • 52 Week Low Date02/03/22

Key Stats

  • Market Cap479.36M
  • Shares Out377.45M
  • 10 Day Average Volume2.97M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change4.1

KEY STATS

  • Open1.34
  • Day High1.36
  • Day Low1.26
  • Prev Close1.33
  • 52 Week High2.23
  • 52 Week High Date06/18/21
  • 52 Week Low0.99
  • 52 Week Low Date02/03/22
  • Market Cap479.36M
  • Shares Out377.45M
  • 10 Day Average Volume2.97M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change4.1

RATIOS/PROFITABILITY

  • EPS (TTM)-0.36
  • P/E (TTM)-3.54
  • Fwd P/E (NTM)-3.11
  • EBITDA (TTM)-113.996M
  • ROE (TTM)-79.28%
  • Revenue (TTM)1.38M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-8,584.92%
  • Debt To Equity (MRQ)51.47%

EVENTS

  • Earnings Date08/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Geron Corp

There is no recent news for this security.

Profile

MORE
Geron Corporation is a late-stage clinical biopharmaceutical company, which is focused on the development and commercialization of imetelstat, a therapeutic for hematologic myeloid malignancies. The Company operates through a single segment, which is engaged in the development of therapeutic products for oncology. Imetelstat is a lipid conjugated 13-mer oligonucleotide that is designed to be complementary to and bind with high affinity to the ribonucleic acid (RNA) template...
John Scarlett M.D.
Chairman of the Board, President, Chief Executive Officer
Andrew Grethlein Ph.D.
Executive Vice President, Chief Operating Officer
Olivia Bloom CPA
Chief Financial Officer, Executive Vice President - Finance, Treasurer
Stephen Rosenfield J.D.
Executive Vice President, Corporate Secretary, Chief Legal Officer
Anil Kapur
Executive Vice President, Corporate Strategy and Chief Commercial Officer
Address
919 EAST HILLSDALE BOULEVARD, SUITE 250
Foster City, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
INO
Inovio Pharmaceuticals Inc
1.92+0.04+2.13%
CNTA
Centessa Pharmaceuticals PLC
4.49-0.06-1.32%
JANX
Janux Therapeutics Inc
11.11+0.76+7.34%
NKTX
Nkarta Inc
12.77+0.10+0.79%
KNTE
Kinnate Biopharma Inc
11.05+0.72+6.97%